A report by Arcview Market Research indicates that legal cannabis will grow at 22% CAGR in 2017, as eight states that voted to open or expand their cannabis markets on Election Day in November 2016. According to the report, the industry accelerated at a remarkable pace in 2016. North American consumers spent $6.7 billion on legal cannabis products, or up 34% from 2015. The 34% compound annual growth rate (CAGR) from 2014 to 2016 was driven primarily by Colorado and Washington initiating adult-use sales. Global Payout, Inc. (OTC: GOHE), SinglePoint, Inc. (OTC: SING), GreenGro Technologies, Inc. (OTC: GRNH), OWC Pharmaceutical Research Corp. (OTC: OWCP), AXIM Biotechnologies, Inc. (OTC: AXIM).
A research published by New Frontier Data shows how the pharmaceutical market will be influenced by medical cannabis. “The United States constitutes 35% of the global pharmaceutical market, the largest market in the world, and a major driver of the U.S. economy. It is one of many industries that will be impacted by the